Group One Trading, L.P. Aurinia Pharmaceuticals Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$4.93 - $9.31 $1.49 Million - $2.81 Million	-301,518 Reduced 44.42%	377,322 $1.89 Million
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $673,485 - $896,406	94,458 Added 16.16%	678,840 $6.1 Million
Q3 2023 Nov 09, 2023	BUY	$7.77 - $12.27 $1.69 Million - $2.67 Million	217,289 Added 59.19%	584,382 $4.54 Million
Q2 2023 Aug 09, 2023	BUY	$8.96 - $11.69 $392,098 - $511,566	43,761 Added 13.53%	367,093 $3.55 Million
Q1 2023 May 12, 2023	BUY	$5.94 - $11.27 $40,011 - $75,914	6,736 Added 2.13%	323,332 $3.54 Million
Q4 2022 Feb 09, 2023	SELL	$4.11 - $8.14 $612,772 - $1.21 Million	-149,093 Reduced 32.02%	316,596 $1.37 Million
Q3 2022 Nov 09, 2022	SELL	$6.66 - $12.39 $13,659 - $25,411	-2,051 Reduced 0.44%	465,689 $3.5 Million
Q2 2022 Aug 11, 2022	BUY	$8.95 - $12.8 $749,965 - $1.07 Million	83,795 Added 21.82%	467,740 $4.7 Million
Q1 2022 May 12, 2022	BUY	$10.05 - $22.48 $3.57 Million - $7.99 Million	355,207 Added 1236.02%	383,945 $4.75 Million
Q4 2021 Feb 11, 2022	SELL	$17.78 - $33.08 $486,265 - $904,704	-27,349 Reduced 48.76%	28,738 $657,000
Q3 2021 Nov 12, 2021	SELL	$10.93 - $23.55 $2.47 Million - $5.31 Million	-225,564 Reduced 80.09%	56,087 $1.24 Million
Q2 2021 Aug 10, 2021	BUY	$10.0 - $14.52 $1.2 Million - $1.74 Million	120,178 Added 74.43%	281,651 $3.65 Million
Q1 2021 May 12, 2021	SELL	$12.3 - $18.73 $1.92 Million - $2.93 Million	-156,483 Reduced 49.22%	161,473 $2.1 Million
Q4 2020 Feb 10, 2021	SELL	$12.94 - $16.05 $325,272 - $403,448	-25,137 Reduced 7.33%	317,956 $4.4 Million
Q3 2020 Nov 12, 2020	BUY	$13.19 - $16.66 $974,239 - $1.23 Million	73,862 Added 27.43%	343,093 $5.05 Million
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $719,512 - $934,041	50,957 Added 23.35%	269,231 $4.38 Million
Q1 2020 May 13, 2020	BUY	$11.34 - $21.46 $539,228 - $1.02 Million	47,551 Added 27.85%	218,274 $3.17 Million
Q4 2019 Feb 10, 2020	BUY	$3.88 - $21.42 $402,615 - $2.22 Million	103,767 Added 154.98%	170,723 $3.46 Million
Q3 2019 Nov 12, 2019	BUY	$5.34 - $6.59 $292,151 - $360,538	54,710 Added 446.76%	66,956 $358,000
Q2 2019 Aug 09, 2019	BUY	$6.05 - $6.75 $47,716 - $53,237	7,887 Added 180.94%	12,246 $81,000
Q1 2019 May 13, 2019	SELL	$6.06 - $7.64 $290,237 - $365,910	-47,894 Reduced 91.66%	4,359 $28,000
Q4 2018 Feb 06, 2019	SELL	$5.08 - $6.83 $321,238 - $431,901	-63,236 Reduced 54.75%	52,253 $356,000
Q3 2018 Nov 08, 2018	BUY	$5.27 - $6.64 $188,133 - $237,041	35,699 Added 44.74%	115,489 $767,000
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.36 $339,328 - $426,507	-67,061 Reduced 45.67%	79,790 $449,000
Q1 2018 May 11, 2018	SELL	$4.85 - $5.99 $390,007 - $481,679	-80,414 Reduced 35.38%	146,851 $762,000
Q4 2017 Feb 09, 2018	SELL	$4.53 - $7.09 $156,728 - $245,299	-34,598 Reduced 13.21%	227,265 $1.03 Million
Q3 2017 Nov 15, 2017	BUY	$5.71 - $6.9 $150,721 - $182,132	26,396 Added 11.21%	261,863 $1.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	235,467	235,467 $1.44 Million

Others Institutions Holding AUPH

# of Institutions

191

Shares Held

56.2M

Call Options Held

499K

Put Options Held

637K

Armistice Capital, LLC New York, NY

11.1M
Shares

$81.1 Million
0.83% of portfolio
Black Rock Inc. New York, NY

9.27M
Shares

$67.5 Million
0.0% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$28.9 Million
2.14% of portfolio
State Street Corp Boston, MA

2.88M
Shares

$21 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.78M
Shares

$20.2 Million
1.94% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account